compass data analysis 5 0 software Search Results


90
Becton Dickinson matrigel
Matrigel, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compass+data+analysis+5+0+software/matrigel/pmc05225427-108-5-7
Average 90 stars, based on 1 article reviews
matrigel - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

94
Thermo Fisher cesium hydroxide
Cesium Hydroxide, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compass+data+analysis+5+0+software/Cesium+hydroxide%2C+99%2E9%25%2C+(trace+metal+basis)%2C+for+analysis%2C+50+wt%25+solution+in+water/10__1016_slash_j__cejgas__2026__100036-50-4-16
Average 94 stars, based on 1 article reviews
cesium hydroxide - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

99
Bruker Corporation compass data analysis 5 0 software
Compass Data Analysis 5 0 Software, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compass+data+analysis+5+0+software/Compass/10__1039_slash_d4nj01223b-91-7-6
Average 99 stars, based on 1 article reviews
compass data analysis 5 0 software - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

90
Becton Dickinson 50 µ l matrigel
50 µ L Matrigel, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compass+data+analysis+5+0+software/matrigel+solution/pmc07252468-68-6-7
Average 90 stars, based on 1 article reviews
50 µ l matrigel - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
synaptosoft inc mini analysis 5.0
Mini Analysis 5.0, supplied by synaptosoft inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compass+data+analysis+5+0+software/mini+analysis+software/10__1161_slash_circresaha__107__157271-149-6-9
Average 90 stars, based on 1 article reviews
mini analysis 5.0 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

99
Thermo Fisher propidium iodide
Propidium Iodide, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compass+data+analysis+5+0+software/Propidium+iodide%2C+95%25/pm39179335-57-4-6
Average 99 stars, based on 1 article reviews
propidium iodide - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

90
Promega celltiter-glo reagent
Dynamic Yap activity is required for the outgrowth of colorectal cancer organoids. A, Diminishing expression of micro-organoid–associated genes during the first 7 days of A/K/P/S organoid outgrowth. Gene expression, represented as mean + SEM, is normalized to day 1. B–D, Single A/K/P/S cells treated with 500 nmol/L XMU-MP-1 (MST1/2 inhibitor) for 3 or 7 days. B, Schematic of experimental setup (top) and representative organoid overview after 7 days of culture (bottom). Scale bars, 100 µm. C, Relative fraction of EdU-incorporating cells. D, Flow analysis of STAR levels. C and D, Data is normalized to DMSO control. E–H, Ten-day-old A/K/P/S organoids were treated with 500 nmol/L XMU-MP-1 and analyzed after 96 hours by flow cytometry. E, Experimental setup. F, Relative viability assessed by DAPI. G, Relative change in STAR populations. H, Relative fraction of EdU-incorporating cells. F–H, Data are normalized to their respective DMSO control. I–J, Three µmol/L verteporfin was added to single A/K/P/S cells for 48 hours prior to wash out. Organoids were analyzed after 7 days. I, Schematic of experimental setup (top) and representative organoid overview after 7 days of culture (bottom). Scale bars, 100 µm. J, Relative viability as assessed by <t>CellTiter-Glo.</t> Data are normalized to DMSO control. n.s., nonsignificant; *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Celltiter Glo Reagent, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compass+data+analysis+5+0+software/celltiter+glo+luminescent+cell+viability+assay/pmc09381095-77-3-6
Average 90 stars, based on 1 article reviews
celltiter-glo reagent - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

99
Eppendorf AG amber polypropylene tubes
Dynamic Yap activity is required for the outgrowth of colorectal cancer organoids. A, Diminishing expression of micro-organoid–associated genes during the first 7 days of A/K/P/S organoid outgrowth. Gene expression, represented as mean + SEM, is normalized to day 1. B–D, Single A/K/P/S cells treated with 500 nmol/L XMU-MP-1 (MST1/2 inhibitor) for 3 or 7 days. B, Schematic of experimental setup (top) and representative organoid overview after 7 days of culture (bottom). Scale bars, 100 µm. C, Relative fraction of EdU-incorporating cells. D, Flow analysis of STAR levels. C and D, Data is normalized to DMSO control. E–H, Ten-day-old A/K/P/S organoids were treated with 500 nmol/L XMU-MP-1 and analyzed after 96 hours by flow cytometry. E, Experimental setup. F, Relative viability assessed by DAPI. G, Relative change in STAR populations. H, Relative fraction of EdU-incorporating cells. F–H, Data are normalized to their respective DMSO control. I–J, Three µmol/L verteporfin was added to single A/K/P/S cells for 48 hours prior to wash out. Organoids were analyzed after 7 days. I, Schematic of experimental setup (top) and representative organoid overview after 7 days of culture (bottom). Scale bars, 100 µm. J, Relative viability as assessed by <t>CellTiter-Glo.</t> Data are normalized to DMSO control. n.s., nonsignificant; *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Amber Polypropylene Tubes, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compass+data+analysis+5+0+software/Eppendorf/pmc12913760-133-10-13
Average 99 stars, based on 1 article reviews
amber polypropylene tubes - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

99
Thermo Fisher neutravidin agarose beads
A. Structures and dose-response curves of (S)-CCZ, CCZ-diazirine, CCZ-diazirine-biotin (CCZ-DB) and diazirine-biotin (DB) control. CCZ-diazirine and CCZ-diazirine-biotin were active in inhibiting HCV in the HCV infection assay, with EC50 of 25.0 nM and 19.7 nM, respectively. The DB control has the diazirine-biotin moieties but was not active against HCV. B. Cross-linking of CCZ-DB with recombinant HCV E1/E2 protein. Purified recombinant E1/E2 protein (genotype 1a) was incubated with various compounds described above at room temperature for 1 h, subjected to UV cross-linking and then purified by <t>Neutravidin</t> beads followed by Western blot with anti-E1 antibody. Recombinant E1/E2 protein was included on the blot as a reference. In one sample, a 100-fold higher concentration of (S)-CCZ (100 μM) was added to the CCZ-DB cross-linking condition. C. Cross-linking of CCZ-DB with E1 protein of HCV genotype 1a-infected cells. Huh7.5.1 cells were infected with high-titer HCVcc genotype 1a virus in the presence of the various compounds at 37°C for 1 h, subjected to UV cross-linking and then lysed for purification by Neutravidin beads followed by Western blot with anti-E1 antibody. The same conditions were tested as the HCV recombinant E1/E2 protein above. A high-titer stock of the HCV genotype 1a virus was also run on the blot to demonstrate the presence of E1 protein. The results are representative of three separate experiments.
Neutravidin Agarose Beads, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compass+data+analysis+5+0+software/Agarose/pmc07368827-552-14-17
Average 99 stars, based on 1 article reviews
neutravidin agarose beads - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

90
RStudio rstudio software 2023.12.1.402
A. Structures and dose-response curves of (S)-CCZ, CCZ-diazirine, CCZ-diazirine-biotin (CCZ-DB) and diazirine-biotin (DB) control. CCZ-diazirine and CCZ-diazirine-biotin were active in inhibiting HCV in the HCV infection assay, with EC50 of 25.0 nM and 19.7 nM, respectively. The DB control has the diazirine-biotin moieties but was not active against HCV. B. Cross-linking of CCZ-DB with recombinant HCV E1/E2 protein. Purified recombinant E1/E2 protein (genotype 1a) was incubated with various compounds described above at room temperature for 1 h, subjected to UV cross-linking and then purified by <t>Neutravidin</t> beads followed by Western blot with anti-E1 antibody. Recombinant E1/E2 protein was included on the blot as a reference. In one sample, a 100-fold higher concentration of (S)-CCZ (100 μM) was added to the CCZ-DB cross-linking condition. C. Cross-linking of CCZ-DB with E1 protein of HCV genotype 1a-infected cells. Huh7.5.1 cells were infected with high-titer HCVcc genotype 1a virus in the presence of the various compounds at 37°C for 1 h, subjected to UV cross-linking and then lysed for purification by Neutravidin beads followed by Western blot with anti-E1 antibody. The same conditions were tested as the HCV recombinant E1/E2 protein above. A high-titer stock of the HCV genotype 1a virus was also run on the blot to demonstrate the presence of E1 protein. The results are representative of three separate experiments.
Rstudio Software 2023.12.1.402, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compass+data+analysis+5+0+software/rstudio+version+1+3+1093/pm39527638-200-7-0
Average 90 stars, based on 1 article reviews
rstudio software 2023.12.1.402 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Soft Imaging System GmbH analysis 5.0
A. Structures and dose-response curves of (S)-CCZ, CCZ-diazirine, CCZ-diazirine-biotin (CCZ-DB) and diazirine-biotin (DB) control. CCZ-diazirine and CCZ-diazirine-biotin were active in inhibiting HCV in the HCV infection assay, with EC50 of 25.0 nM and 19.7 nM, respectively. The DB control has the diazirine-biotin moieties but was not active against HCV. B. Cross-linking of CCZ-DB with recombinant HCV E1/E2 protein. Purified recombinant E1/E2 protein (genotype 1a) was incubated with various compounds described above at room temperature for 1 h, subjected to UV cross-linking and then purified by <t>Neutravidin</t> beads followed by Western blot with anti-E1 antibody. Recombinant E1/E2 protein was included on the blot as a reference. In one sample, a 100-fold higher concentration of (S)-CCZ (100 μM) was added to the CCZ-DB cross-linking condition. C. Cross-linking of CCZ-DB with E1 protein of HCV genotype 1a-infected cells. Huh7.5.1 cells were infected with high-titer HCVcc genotype 1a virus in the presence of the various compounds at 37°C for 1 h, subjected to UV cross-linking and then lysed for purification by Neutravidin beads followed by Western blot with anti-E1 antibody. The same conditions were tested as the HCV recombinant E1/E2 protein above. A high-titer stock of the HCV genotype 1a virus was also run on the blot to demonstrate the presence of E1 protein. The results are representative of three separate experiments.
Analysis 5.0, supplied by Soft Imaging System GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compass+data+analysis+5+0+software/analysis+5+0/us09623381-490-5-8
Average 90 stars, based on 1 article reviews
analysis 5.0 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

99
Danaher Inc gf c filter
A. Structures and dose-response curves of (S)-CCZ, CCZ-diazirine, CCZ-diazirine-biotin (CCZ-DB) and diazirine-biotin (DB) control. CCZ-diazirine and CCZ-diazirine-biotin were active in inhibiting HCV in the HCV infection assay, with EC50 of 25.0 nM and 19.7 nM, respectively. The DB control has the diazirine-biotin moieties but was not active against HCV. B. Cross-linking of CCZ-DB with recombinant HCV E1/E2 protein. Purified recombinant E1/E2 protein (genotype 1a) was incubated with various compounds described above at room temperature for 1 h, subjected to UV cross-linking and then purified by <t>Neutravidin</t> beads followed by Western blot with anti-E1 antibody. Recombinant E1/E2 protein was included on the blot as a reference. In one sample, a 100-fold higher concentration of (S)-CCZ (100 μM) was added to the CCZ-DB cross-linking condition. C. Cross-linking of CCZ-DB with E1 protein of HCV genotype 1a-infected cells. Huh7.5.1 cells were infected with high-titer HCVcc genotype 1a virus in the presence of the various compounds at 37°C for 1 h, subjected to UV cross-linking and then lysed for purification by Neutravidin beads followed by Western blot with anti-E1 antibody. The same conditions were tested as the HCV recombinant E1/E2 protein above. A high-titer stock of the HCV genotype 1a virus was also run on the blot to demonstrate the presence of E1 protein. The results are representative of three separate experiments.
Gf C Filter, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compass+data+analysis+5+0+software/Filter/10__1016_slash_j__algal__2015__02__005-50-15-14
Average 99 stars, based on 1 article reviews
gf c filter - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

Image Search Results


Dynamic Yap activity is required for the outgrowth of colorectal cancer organoids. A, Diminishing expression of micro-organoid–associated genes during the first 7 days of A/K/P/S organoid outgrowth. Gene expression, represented as mean + SEM, is normalized to day 1. B–D, Single A/K/P/S cells treated with 500 nmol/L XMU-MP-1 (MST1/2 inhibitor) for 3 or 7 days. B, Schematic of experimental setup (top) and representative organoid overview after 7 days of culture (bottom). Scale bars, 100 µm. C, Relative fraction of EdU-incorporating cells. D, Flow analysis of STAR levels. C and D, Data is normalized to DMSO control. E–H, Ten-day-old A/K/P/S organoids were treated with 500 nmol/L XMU-MP-1 and analyzed after 96 hours by flow cytometry. E, Experimental setup. F, Relative viability assessed by DAPI. G, Relative change in STAR populations. H, Relative fraction of EdU-incorporating cells. F–H, Data are normalized to their respective DMSO control. I–J, Three µmol/L verteporfin was added to single A/K/P/S cells for 48 hours prior to wash out. Organoids were analyzed after 7 days. I, Schematic of experimental setup (top) and representative organoid overview after 7 days of culture (bottom). Scale bars, 100 µm. J, Relative viability as assessed by CellTiter-Glo. Data are normalized to DMSO control. n.s., nonsignificant; *, P < 0.05; **, P < 0.01; ***, P < 0.001.

Journal: Cancer Research

Article Title: Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic Stage

doi: 10.1158/0008-5472.CAN-21-0933

Figure Lengend Snippet: Dynamic Yap activity is required for the outgrowth of colorectal cancer organoids. A, Diminishing expression of micro-organoid–associated genes during the first 7 days of A/K/P/S organoid outgrowth. Gene expression, represented as mean + SEM, is normalized to day 1. B–D, Single A/K/P/S cells treated with 500 nmol/L XMU-MP-1 (MST1/2 inhibitor) for 3 or 7 days. B, Schematic of experimental setup (top) and representative organoid overview after 7 days of culture (bottom). Scale bars, 100 µm. C, Relative fraction of EdU-incorporating cells. D, Flow analysis of STAR levels. C and D, Data is normalized to DMSO control. E–H, Ten-day-old A/K/P/S organoids were treated with 500 nmol/L XMU-MP-1 and analyzed after 96 hours by flow cytometry. E, Experimental setup. F, Relative viability assessed by DAPI. G, Relative change in STAR populations. H, Relative fraction of EdU-incorporating cells. F–H, Data are normalized to their respective DMSO control. I–J, Three µmol/L verteporfin was added to single A/K/P/S cells for 48 hours prior to wash out. Organoids were analyzed after 7 days. I, Schematic of experimental setup (top) and representative organoid overview after 7 days of culture (bottom). Scale bars, 100 µm. J, Relative viability as assessed by CellTiter-Glo. Data are normalized to DMSO control. n.s., nonsignificant; *, P < 0.05; **, P < 0.01; ***, P < 0.001.

Article Snippet: For analysis, 50% v/v CellTiter-Glo reagent (Promega) was added to each well.

Techniques: Activity Assay, Expressing, Control, Flow Cytometry

A. Structures and dose-response curves of (S)-CCZ, CCZ-diazirine, CCZ-diazirine-biotin (CCZ-DB) and diazirine-biotin (DB) control. CCZ-diazirine and CCZ-diazirine-biotin were active in inhibiting HCV in the HCV infection assay, with EC50 of 25.0 nM and 19.7 nM, respectively. The DB control has the diazirine-biotin moieties but was not active against HCV. B. Cross-linking of CCZ-DB with recombinant HCV E1/E2 protein. Purified recombinant E1/E2 protein (genotype 1a) was incubated with various compounds described above at room temperature for 1 h, subjected to UV cross-linking and then purified by Neutravidin beads followed by Western blot with anti-E1 antibody. Recombinant E1/E2 protein was included on the blot as a reference. In one sample, a 100-fold higher concentration of (S)-CCZ (100 μM) was added to the CCZ-DB cross-linking condition. C. Cross-linking of CCZ-DB with E1 protein of HCV genotype 1a-infected cells. Huh7.5.1 cells were infected with high-titer HCVcc genotype 1a virus in the presence of the various compounds at 37°C for 1 h, subjected to UV cross-linking and then lysed for purification by Neutravidin beads followed by Western blot with anti-E1 antibody. The same conditions were tested as the HCV recombinant E1/E2 protein above. A high-titer stock of the HCV genotype 1a virus was also run on the blot to demonstrate the presence of E1 protein. The results are representative of three separate experiments.

Journal: Cell chemical biology

Article Title: Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1

doi: 10.1016/j.chembiol.2020.04.006

Figure Lengend Snippet: A. Structures and dose-response curves of (S)-CCZ, CCZ-diazirine, CCZ-diazirine-biotin (CCZ-DB) and diazirine-biotin (DB) control. CCZ-diazirine and CCZ-diazirine-biotin were active in inhibiting HCV in the HCV infection assay, with EC50 of 25.0 nM and 19.7 nM, respectively. The DB control has the diazirine-biotin moieties but was not active against HCV. B. Cross-linking of CCZ-DB with recombinant HCV E1/E2 protein. Purified recombinant E1/E2 protein (genotype 1a) was incubated with various compounds described above at room temperature for 1 h, subjected to UV cross-linking and then purified by Neutravidin beads followed by Western blot with anti-E1 antibody. Recombinant E1/E2 protein was included on the blot as a reference. In one sample, a 100-fold higher concentration of (S)-CCZ (100 μM) was added to the CCZ-DB cross-linking condition. C. Cross-linking of CCZ-DB with E1 protein of HCV genotype 1a-infected cells. Huh7.5.1 cells were infected with high-titer HCVcc genotype 1a virus in the presence of the various compounds at 37°C for 1 h, subjected to UV cross-linking and then lysed for purification by Neutravidin beads followed by Western blot with anti-E1 antibody. The same conditions were tested as the HCV recombinant E1/E2 protein above. A high-titer stock of the HCV genotype 1a virus was also run on the blot to demonstrate the presence of E1 protein. The results are representative of three separate experiments.

Article Snippet: Affinity Pull-Down of CCZ-DB Cross-Linked Proteins and Western Blot Analysis 50 μL of Pierce NeutrAvidin agarose beads (Thermo Fischer Scientific, Waltham, MA, USA) were spun down, the supernatant was discarded, and the beads were washed twice with 1 mL of PBS.

Techniques: Infection, Recombinant, Purification, Incubation, Western Blot, Concentration Assay

Key Resources Table

Journal: Cell chemical biology

Article Title: Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1

doi: 10.1016/j.chembiol.2020.04.006

Figure Lengend Snippet: Key Resources Table

Article Snippet: Affinity Pull-Down of CCZ-DB Cross-Linked Proteins and Western Blot Analysis 50 μL of Pierce NeutrAvidin agarose beads (Thermo Fischer Scientific, Waltham, MA, USA) were spun down, the supernatant was discarded, and the beads were washed twice with 1 mL of PBS.

Techniques: Recombinant, Plasmid Preparation, Luciferase, Purification, Mutagenesis, Clone Assay, Western Blot, Software, Sequencing